Document Detail


Effect of valsartan on renal handling of uric acid in healthy subjects.
MedLine Citation:
PMID:  10858975     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the effect of valsartan on renal handling of uric acid in healthy subjects. METHODS: A randomized, single-blind, placebo-controlled clinical trial was performed in twelve healthy volunteers. Six received a morning dose of valsartan 80 mg orally during 14 to 21 days and the other six received placebo. Before and after valsartan or placebo, clearance, fractional excretion and excretion uric acid rates were calculated. Presecretory reabsorption, tubular secretion and postsecretory reabsorption of uric acid were assessed by pharmacological tests using pyrazinamide or probenecid. RESULTS: There were no differences in clearance, fractional excretion and excretion uric acid rates with valsartan and placebo. Valsartan did not affect presecretory reabsorption (p = 0.92), tubular secretion (p = 0.62) or postsecretory reabsorption (p = 0.52) of uric acid. CONCLUSION: Valsartan did not significantly affect renal handling of uric acid in healthy subjects.
Authors:
M Gonz?lez-Ortiz; J M Mora-Mart?nez; E Mart?nez-Abundis; B R Balc?zar-Mu?oz
Related Documents :
20064695 - Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?
3921445 - Visual evoked potential recordings in hepatic encephalopathy and their variations durin...
19903375 - Montmorillonite adsorbs uric acid and increases the excretion of uric acid from the int...
8413795 - Effect of lactate infusion on renal transport of purine bases and oxypurinol.
19015135 - Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-i...
15535185 - Modulated photoacoustic spectroscopy study of an artificial tanning on human skin induc...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of nephrology     Volume:  13     ISSN:  1121-8428     ISO Abbreviation:  J. Nephrol.     Publication Date:    2000 Mar-Apr
Date Detail:
Created Date:  2000-10-26     Completed Date:  2000-10-26     Revised Date:  2010-05-31    
Medline Journal Info:
Nlm Unique ID:  9012268     Medline TA:  J Nephrol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  126-8     Citation Subset:  IM    
Affiliation:
Medical Research Unit in Clinical Epidemiology, West National Medical Center, Mexican Institute of Social Security, Guadalajara City, Jalisco. uiec@prodigy.net.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Humans
Kidney / drug effects*,  metabolism*
Male
Single-Blind Method
Tetrazoles / pharmacology*
Uric Acid / metabolism*
Valine / analogs & derivatives*,  pharmacology
Chemical
Reg. No./Substance:
0/Tetrazoles; 137862-53-4/valsartan; 69-93-2/Uric Acid; 7004-03-7/Valine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transtubular potassium concentration gradient (TTKG) and urine ammonium in differential diagnosis of...
Next Document:  Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis ...